Behavior Changes After Notification of HIV Infection
Overview
Affiliations
Background: To learn more about how people who did not volunteer for testing react to information about HIV infection, we assessed short-term behavior changes in HIV-positive blood donors.
Methods: Blood donors who were notified at the New York Blood Center that they were HIV positive were asked to participate in a study. A nurse elicited a medical history, performed a limited medical examination, and asked participants to complete a questionnaire that included questions about drug use, sexual behavior, and psychological characteristics. Participants were asked to return in 2 weeks to complete another questionnaire.
Results: Many fewer men and women reported engaging in unsafe sexual behaviors in the 2 weeks preceding the follow-up visit than had reported such behaviors prior to notification. These changes were greater than those other investigators have reported, but about 40% of the participants still reported unsafe sexual activity at the follow-up interview.
Conclusions: To make nonvolunteer screening programs for HIV infection more effective in reducing the spread of HIV infection, we need to learn more about how to help people change their high-risk behaviors.
Kosmider E, Wallner J, Gervassi A, Bender Ignacio R, Pinto-Santini D, Gornalusse G PLoS One. 2024; 19(7):e0288895.
PMID: 38976697 PMC: 11230552. DOI: 10.1371/journal.pone.0288895.
Primary Care of the Person Living with HIV.
Kasten M Pathogens. 2022; 11(4).
PMID: 35456055 PMC: 9025375. DOI: 10.3390/pathogens11040380.
Lundon D, Kelly B, Nair S, Bolton D, Patel G, Reich D Front Med (Lausanne). 2021; 8:563465.
PMID: 33996839 PMC: 8116585. DOI: 10.3389/fmed.2021.563465.
A Pilot RCT Evaluating InThistoGether, an mHealth HIV Prevention Program for Ugandan Youth.
Ybarra M, Agaba E, Nyemara N AIDS Behav. 2021; 25(10):3437-3448.
PMID: 33963477 PMC: 10159628. DOI: 10.1007/s10461-021-03237-5.
Structural Design and Data Requirements for Simulation Modelling in HIV/AIDS: A Narrative Review.
Zang X, Krebs E, Wang L, Marshall B, Granich R, Schackman B Pharmacoeconomics. 2019; 37(10):1219-1239.
PMID: 31222521 PMC: 6711792. DOI: 10.1007/s40273-019-00817-1.